[1]
2010. IN SILICO INVESTIGATION AND DOCKING STUDIES OF E2F3 TUMOR MARKER: DISCOVERY AND EVALUATION OF POTENTIAL INHIBITORS FOR PROSTATE AND BREAST CANCER. International Journal of Pharmaceutical Sciences and Drug Research. 2, 4 (Oct. 2010), 254–260. DOI:https://doi.org/10.25004/IJPSDR.2010.020405.